FOXA1 promotes tumor progression in prostate cancer and represents a novel hallmark of castration-resistant prostate cancer

American Journal of Pathology

Volumn 180, Issue 2, 2012, Pages 848-861

  Gerhardt, Josefine ^a   Montani, Matteo ^b   Wild, Peter ^a   Beer, Marc ^a   Huber, Fabian ^a   Hermanns, Thomas ^a   Mntener, Michael ^a   Kristiansen, Glen ^c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER CELL; CANCER STAGING; CARCINOGENICITY; CASTRATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; TUMOR GROWTH;

AGED; CELL PROLIFERATION; DISEASE PROGRESSION; G1 PHASE CELL CYCLE CHECKPOINTS; GENE KNOCKDOWN TECHNIQUES; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; ORCHIECTOMY; PROGNOSIS; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84855987529     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.10.021     Document Type: Article

References (58)

1. P. Boyle, B. Levin World Cancer Report 2008 2008 WHO-IARC Lyon 22
2. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
3. C. Huggins, C.V. Hodges Studies on prostatic cancer I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate CA Cancer J Clin 22 1972 232 240
4. L.G. Horvath, S.M. Henshall, C.S. Lee, D.R. Head, D.I. Quinn, S. Makela, W. Delprado, D. Golovsky, P.C. Brenner, G. O'Neill, R. Kooner, P.D. Stricker, J.J. Grygiel, J.A. Gustafsson, R.L. Sutherland Frequent loss of estrogen receptor-beta expression in prostate cancer Cancer Res 61 2001 5331 5335
5. C.D. Chen, D.S. Welsbie, C. Tran, S.H. Baek, R. Chen, R. Vessella, M.G. Rosenfeld, C.L. Sawyers Molecular determinants of resistance to antiandrogen therapy Nat Med 10 2004 33 39
6. G. Kristiansen, C. Pilarsky, C. Wissmann, S. Kaiser, T. Bruemmendorf, S. Roepcke, E. Dahl, B. Hinzmann, T. Specht, J. Pervan, C. Stephan, S. Loening, M. Dietel, A. Rosenthal Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival J Pathol 205 2005 359 376
7. E. Lai, V.R. Prezioso, W.F. Tao, W.S. Chen, J.E. Darnell Jr Hepatocyte nuclear factor 3 alpha belongs to a gene family in mammals that is homologous to the Drosophila homeotic gene fork head Genes Dev 5 1991 416 427
8. E. Lai, V.R. Prezioso, E. Smith, O. Litvin, R.H. Costa, J.E. Darnell Jr HNF-3A, a hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally Genes Dev 4 1990 1427 1436
9. R.H. Costa, D.R. Grayson, J.E. Darnell Jr Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and alpha 1-antitrypsin genes Mol Cell Biol 9 1989 1415 1425
10. D. Weigel, H. Jckle The fork head domain: a novel DNA binding motif of eukaryotic transcription factors Cell 63 1990 455 456
11. K.L. Clark, E.D. Halay, E. Lai, S.K. Burley Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5 Nature 364 1993 412 420
12. L.A. Cirillo, F.R. Lin, I. Cuesta, D. Friedman, M. Jarnik, K.S. Zaret Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4 Mol Cell 9 2002 279 289
13. J.S. Carroll, X.S. Liu, A.S. Brodsky, W. Li, C.A. Meyer, A.J. Szary, J. Eeckhoute, W. Shao, E.V. Hestermann, T.R. Geistlinger, E.A. Fox, P.A. Silver, M. Brown Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1 Cell 122 2005 33 43
14. J. Laganire, G. Deblois, C. Lefebvre, A.R. Bataille, F. Robert, V. Giguere From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response Proc Natl Acad Sci USA 102 2005 11651 11656
15. N. Gao, K. Ishii, J. Mirosevich, S. Kuwajima, S.R. Oppenheimer, R.L. Roberts, M. Jiang, X. Yu, S.B. Shappell, R.M. Caprioli, M. Stoffel, S.W. Hayward, R.J. Matusik Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation Development 132 2005 3431 3443
16. N. Gao, J. Zhang, M.A. Rao, T.C. Case, J. Mirosevich, Y. Wang, R. Jin, A. Gupta, P.S. Rennie, R.J. Matusik The role of hepatocyte nuclear factor-3 alpha (forkhead box A1) and androgen receptor in transcriptional regulation of prostatic genes Mol Endocrinol 17 2003 1484 1507
17. L. Jia, B.P. Berman, U. Jariwala, X. Yan, J.P. Cogan, A. Walters, T. Chen, G. Buchanan, B. Frenkel, G.A. Coetzee Genomic androgen receptor-occupied regions with different functions, defined by histone acetylation, coregulators and transcriptional capacity PLoS One 3 2008 e3645
18. H.J. Lee, M. Hwang, S. Chattopadhyay, H.S. Choi, K. Lee Hepatocyte nuclear factor-3 alpha (HNF-3alpha) negatively regulates androgen receptor transactivation in prostate cancer cells Biochem Biophys Res Commun 367 2008 481 486
19. X. Yu, A. Gupta, Y. Wang, K. Suzuki, J. Mirosevich, M.C. Orgebin-Crist, R.J. Matusik Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially Ann N Y Acad Sci 1061 2005 77 93
20. I. Wolf, S. Bose, E.A. Williamson, C.W. Miller, B.Y. Karlan, H.P. Koeffler FOXA1: growth inhibitor and a favorable prognostic factor in human breast cancer Int J Cancer 120 2007 1013 1022
21. H. Wan, S. Dingle, Y. Xu, V. Besnard, K.H. Kaestner, S.L. Ang, S. Wert, M.T. Stahlman, J.A. Whitsett Compensatory roles of Foxa1 and Foxa2 during lung morphogenesis J Biol Chem 280 2005 13809 13816
22. J. Mirosevich, N. Gao, R.J. Matusik Expression of Foxa transcription factors in the developing and adult murine prostate Prostate 62 2005 339 352
23. J.R. Friedman, K.H. Kaestner The Foxa family of transcription factors in development and metabolism Cell Mol Life Sci 63 2006 2317 2328
24. K.H. Kaestner, J. Katz, Y. Liu, D.J. Drucker, G. Schtz Inactivation of the winged helix transcription factor HNF3alpha affects glucose homeostasis and islet glucagon gene expression in vivo Genes Dev 13 1999 495 504
25. C.T. Miller, J.R. Moy, L. Lin, M. Schipper, D. Normolle, D.E. Brenner, M.D. Iannettoni, M.B. Orringer, D.G. Beer Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade dysplasia Clin Cancer Res 9 2003 4819 4825
26. L. Lin, C.T. Miller, J.I. Contreras, M.S. Prescott, S.L. Dagenais, R. Wu, J. Yee, M.B. Orringer, D.E. Misek, S.M. Hanash, T.W. Glover, D.G. Beer The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas Cancer Res 62 2002 5273 5279
27. M.A. Thorat, C. Marchio, A. Morimiya, K. Savage, H. Nakshatri, J.S. Reis-Filho, S. Badve Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis J Clin Pathol 61 2008 327 332
28. H.O. Habashy, D.G. Powe, E.A. Rakha, G. Ball, C. Paish, J. Gee, R.I. Nicholson, I.O. Ellis Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance Eur J Cancer 44 2008 1541 1551
29. S. Badve, D. Turbin, M.A. Thorat, A. Morimiya, T.O. Nielsen, C.M. Perou, S. Dunn, D.G. Huntsman, H. Nakshatri FOXA1 expression in breast cancercorrelation with luminal subtype A and survival Clin Cancer Res 13 2007 4415 4421
30. J. Mirosevich, N. Gao, A. Gupta, S.B. Shappell, R. Jove, R.J. Matusik Expression and role of Foxa proteins in prostate cancer Prostate 66 2006 1013 1028
31. J. Gerhardt, C. Steinbrech, O. Bchi, S. Behnke, A. Bohnert, F. Fritzsche, H. Liewen, F. Stenner, P. Wild, T. Hermanns, M. Mntener, M. Dietel, K. Jung, C. Stephan, G. Kristiansen The androgen-regulated calcium-activated nucleotidase 1 (CANT1) is commonly overexpressed in prostate cancer and is tumor-biologically relevant in vitro Am J Pathol 178 2011 1847 1860
32. V. Tischler, F.R. Fritzsche, P.J. Wild, C. Stephan, H.H. Seifert, M.O. Riener, T. Hermanns, A. Mortezavi, J. Gerhardt, P. Schraml, K. Jung, H. Moch, A. Soltermann, G. Kristiansen Periostin is up-regulated in high grade and high stage prostate cancer BMC Cancer 10 2010 273
33. A. Mortezavi, T. Hermanns, H.H. Seifert, M.K. Baumgartner, M. Provenzano, T. Sulser, M. Burger, M. Montani, K. Ikenberg, F. Hofstdter, A. Hartmann, R. Jaggi, H. Moch, G. Kristiansen, P.J. Wild KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy Clin Cancer Res 17 2011 1111 1121
34. G. Kristiansen, F.R. Fritzsche, K. Wassermann, C. Jger, A. Tlle, M. Lein, C. Stephan, K. Jung, C. Pilarsky, M. Dietel, H. Moch GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics Br J Cancer 99 2008 939 948
35. F. Ohl, M. Jung, C. Xu, C. Stephan, A. Rabien, M. Burkhardt, A. Nitsche, G. Kristiansen, S.A. Loening, A. Radoni, K. Jung Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization? J Mol Med 83 2005 1014 1024
36. D. Hanahan, R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
37. M. Beer, M. Montani, J. Gerhardt, P.J. Wild, T.F. Hany, T. Hermanns, M. Mntener, G. Kristiansen Profiling gastrin-releasing peptide receptor in prostate tissues: clinical implications and molecular correlates Prostate 2011 10.1002/pros.21434 [Epub ahead of press]
38. Y. Zhang, T.Z. Ali, H. Zhou, D.R. D'Souza, Y. Lu, J. Jaffe, Z. Liu, A. Passaniti, A.W. Hamburger ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer Cancer Res 70 2010 240 248
39. J. Gipp, G. Gu, C. Crylen, S. Kasper, W. Bushman Hedgehog pathway activity in the LADY prostate tumor model Mol Cancer 6 2007 19
40. T. Chiaverotti, S.S. Couto, A. Donjacour, J.H. Mao, H. Nagase, R.D. Cardiff, G.R. Cunha, A. Balmain Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer Am J Pathol 172 2008 236 246
41. P. Colombo, C. Patriarca, R.M. Alfano, B. Cassani, G. Ceva Grimaldi, M. Roncalli, S. Bosari, G. Coggi, B. Campo, V.E. Gould Molecular disorders in transitional vs. peripheral zone prostate adenocarcinoma Int J Cancer 94 2001 383 389
42. L. van der Heul-Nieuwenhuijsen, P.J. Hendriksen, T.H. van der Kwast, G. Jenster Gene expression profiling of the human prostate zones BJU Int 98 2006 886 897
43. I. Sakai, K. Harada, T. Kurahashi, K. Yamanaka, I. Hara, H. Miyake Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones Int J Urol 13 2006 368 372
44. S.S. Myatt, E.W. Lam The emerging roles of forkhead box (Fox) proteins in cancer Nat Rev Cancer 7 2007 847 859
45. N. Yamaguchi, E. Ito, S. Azuma, R. Honma, Y. Yanagisawa, A. Nishikawa, M. Kawamura, J. Imai, K. Tatsuta, J. Inoue, K. Semba, S. Watanabe FoxA1 as a lineage-specific oncogene in luminal type breast cancer Biochem Biophys Res Commun 365 2008 711 717
46. M.C. Bosland The role of steroid hormones in prostate carcinogenesis J Natl Cancer Inst Monogr 2000 39 66
47. I. Leav, K.M. Lau, J.Y. Adams, J.E. McNeal, M.E. Taplin, J. Wang, H. Singh, S.M. Ho Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma Am J Pathol 159 2001 79 92
48. A. Latil, I. Biche, D. Vidaud, R. Lidereau, P. Berthon, O. Cussenot, M. Vidaud Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays Cancer Res 61 2001 1919 1926
49. T. Fixemer, K. Remberger, H. Bonkhoff Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma Prostate 54 2003 79 87
50. S. Nanni, V. Benvenuti, A. Grasselli, C. Priolo, A. Aiello, S. Mattiussi, C. Colussi, V. Lirangi, B. Illi, M. D'Eletto, A.M. Cianciulli, M. Gallucci, P. De Carli, S. Sentinelli, M. Mottolese, P. Carlini, L. Strigari, S. Finn, E. Mueller, G. Arcangeli, C. Gaetano, M.C. Capogrossi, R.P. Donnorso, S. Bacchetti, A. Sacchi, A. Pontecorvi, M. Loda, A. Farsetti Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer J Clin Invest 119 2009 1093 1108
51. Y.K. Leung, H.M. Lam, S. Wu, D. Song, L. Levin, L. Cheng, C.L. Wu, S.M. Ho Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion Endocr Relat Cancer 17 2010 675 689
52. S.R. Setlur, K.D. Mertz, Y. Hoshida, F. Demichelis, M. Lupien, S. Perner, A. Sboner, Y. Pawitan, O. Andren, L.A. Johnson, J. Tang, H.O. Adami, S. Calza, A.M. Chinnaiyan, D. Rhodes, S. Tomlins, K. Fall, L.A. Mucci, P.W. Kantoff, M.J. Stampfer, S.O. Andersson, E. Varenhorst, J.E. Johansson, M. Brown, T.R. Golub, M.A. Rubin Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer J Natl Cancer Inst 100 2008 815 825
53. P. Mak, I. Leav, B. Pursell, D. Bae, X. Yang, C.A. Taglienti, L.M. Gouvin, V.M. Sharma, A.M. Mercurio ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading [Erratum appeared in Cancer Cell 2010, 17:622] Cancer Cell 17 2010 319 332
54. L. Bubendorf, J. Kononen, P. Koivisto, P. Schraml, H. Moch, T.C. Gasser, N. Willi, M.J. Mihatsch, G. Sauter, O.P. Kallioniemi Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays Cancer Res 59 1999 803 806
55. T. Visakorpi, E. Hyytinen, P. Koivisto, M. Tanner, R. Keinnen, C. Palmberg, A. Palotie, T. Tammela, J. Isola, O.P. Kallioniemi In vivo amplification of the androgen receptor gene and progression of human prostate cancer Nat Genet 9 1995 401 406
56. M.J. Linja, K.J. Savinainen, O.R. Saramki, T.L. Tammela, R.L. Vessella, T. Visakorpi Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer Cancer Res 61 2001 3550 3555
57. R.K. Jain, R.J. Mehta, H. Nakshatri, M.T. Idrees, S.S. Badve High-level expression of forkhead-box protein A1 in metastatic prostate cancer Histopathology 58 2011 766 772
58. H. Bu, S. Bormann, G. Schfer, W. Horninger, P. Massoner, A. Neeb, V.K. Lakshmanan, D. Maddalo, A. Nestl, H. Sltmann, A.C. Cato, H. Klocker The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection Prostate 71 2010 575 587